ArticleScientific reports2020

A blood-based metabolomics test to distinguish relapsing-remitting and secondary progressive multiple sclerosis: addressing practical considerations for clinical application.

Tianrong Yeo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.